Cite
VMCP Chemotherapy With or Without Interferon-alpha-2 in Newly Diagnosed Patients With Multiple Myeloma.
MLA
Preis, P., et al. “VMCP Chemotherapy With or Without Interferon-Alpha-2 in Newly Diagnosed Patients With Multiple Myeloma.” Onkologie, vol. 12, no. 1, Jan. 1989, pp. 27–29. EBSCOhost, https://doi.org/10.1159/000216593.
APA
Preis, P., Scheithauer, W., Fritz, E., Zielinski, C., Kuehrer, I., Cortelezzi, A., Polli, E., Baldini, L., Pirker, R., Kriegisch, A., & Ludwig, H. (1989). VMCP Chemotherapy With or Without Interferon-alpha-2 in Newly Diagnosed Patients With Multiple Myeloma. Onkologie, 12(1), 27–29. https://doi.org/10.1159/000216593
Chicago
Preis, P., W. Scheithauer, E. Fritz, C. Zielinski, I. Kuehrer, A. Cortelezzi, E. Polli, et al. 1989. “VMCP Chemotherapy With or Without Interferon-Alpha-2 in Newly Diagnosed Patients With Multiple Myeloma.” Onkologie 12 (1): 27–29. doi:10.1159/000216593.